Attached files
| file | filename |
|---|---|
| EX-99.1 - POWER POINT - Riot Blockchain, Inc. | ex99_1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported) February 25, 2010
AspenBio Pharma,
Inc.
(Exact
name of Registrant as specified in its charter)
|
Colorado
|
001-33675
|
84-155338
|
||
|
(State
or other jurisdiction of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification No.)
|
|
1585
South Perry Street
Castle
Rock, Colorado
|
80104
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Registrant’s
telephone number, including area code:
|
(303)
794-2000
|
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
7.01. Regulation FD Disclosure.
The power
point presentation information furnished on Exhibit 99.1 is hereby incorporated
by reference under this Item 7.01 as if fully set forth herein and is
available on the Company’s website.
Item
9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibits
|
99.1
|
Company
information — “Power Point Presentation” dated February
2010
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized
|
AspenBio
Pharma, Inc.
(Registrant)
|
||||
|
February
25, 2010
|
By:
|
/s/
Jeffrey G. McGonegal
|
||
|
Name:
|
Jeffrey
G. McGonegal
|
|||
|
Title:
|
Chief
Financial Officer
|
|||